Dong M - Search Results

1

Albumin-to-Alkaline Phosphatase Ratio as an Independent Prognostic Factor for Overall Survival of Advanced Hepatocellular Carcinoma Patients without Receiving Standard Anti-Cancer Therapies.

Cai X, Chen Z, Chen J, Ma X, Bai M, Wang T, Chen X, Wu D, Wei L, Li X, Lin Q, Wen J, Ruan D, Lin Z, Dong M, Wu X. Cai X, et al. Among authors: dong m. J Cancer. 2018 Jan 1;9(1):189-197. doi: 10.7150/jca.21799. eCollection 2018. J Cancer. 2018. PMID: 29290785 Free PMC article.

2

[Influence of graft-versus-host disease on long-term survival of 26 patients with hematologic malignancies after transplantation].

Lin Q, Dong M, Wang QM, Wen JY, Wu XY. Lin Q, et al. Among authors: dong m. Ai Zheng. 2006 Oct;25(10):1261-5. Ai Zheng. 2006. PMID: 17059772 Chinese.

3

[Serum levels of macrophage migration inhibitory factor and interleukin-8 in hepatocellular carcinoma patients: their correlations with tumor progression and prognosis].

Lin Q, Huang MS, Hu B, Dong M, Wen JY, Wu XY. Lin Q, et al. Among authors: dong m. Zhonghua Gan Zang Bing Za Zhi. 2007 Jun;15(6):463-4. Zhonghua Gan Zang Bing Za Zhi. 2007. PMID: 17594817 Chinese. No abstract available.

4

[Efficiency of prevention and treatment of veno-occlusive disease of the liver after allogeneic stem cell transplantation].

Dong M, Lin Q, Wu XY. Dong M, et al. Ai Zheng. 2008 Jun;27(6):646-9. Ai Zheng. 2008. PMID: 18570742 Free article. Chinese.

5

Prognostic analysis of acute exacerbations of hepatitis-B after chemotherapy in combination with rituximab in 19 patients with lymphoma.

Li X, Lin Q, Dong M, Wen JY, Wei L, Ma XK, Chen ZH, Wu XY. Li X, et al. Among authors: dong m. Leuk Lymphoma. 2010 Sep;51(9):1678-85. doi: 10.3109/10428194.2010.499486. Leuk Lymphoma. 2010. PMID: 20807095

6

The treatment of severe hepatitis B virus reactivation after chemotherapy.

Li X, Xing YF, Lin Q, Dong M, Wan XB, Wu XY. Li X, et al. Among authors: dong m. Nat Rev Clin Oncol. 2012 May 1;9(6):350; author reply 350. doi: 10.1038/nrclinonc.2012.1-c1. Nat Rev Clin Oncol. 2012. PMID: 22547218 No abstract available.

7

Beclin 1 activation enhances chemosensitivity and predicts a favorable outcome for primary duodenal adenocarcinoma.

Wu XY, Chen J, Cao QH, Dong M, Lin Q, Fan XJ, Xia Q, Chen ZH, Liu Q, Wan XB. Wu XY, et al. Among authors: dong m. Tumour Biol. 2013 Apr;34(2):713-22. doi: 10.1007/s13277-012-0599-5. Epub 2012 Dec 7. Tumour Biol. 2013. PMID: 23225331

8

An optimized antiviral modification strategy for prevention of hepatitis B reactivation in patients undergoing prophylactic lamivudine and chemotherapy: a pilot study.

Wu XY, Li X, Chen ZH, Wen JY, Lin Q, Xing YF, Dong M, Wei L, Wang TT, Chen J, Lin ZX, Wan XB, Ruan DY, Ma XK. Wu XY, et al. Among authors: dong m. Tumour Biol. 2013 Apr;34(2):909-18. doi: 10.1007/s13277-012-0626-6. Epub 2012 Dec 27. Tumour Biol. 2013. PMID: 23269606

9

Comparison of current staging systems for advanced hepatocellular carcinoma not amendable to locoregional therapy as inclusion criteria for clinical trials.

Li X, Dong M, Lin Q, Chen ZH, Ma XK, Xing YF, Wan XB, Wen JY, Wei L, Chen J, Wu XY. Li X, et al. Among authors: dong m. Asia Pac J Clin Oncol. 2013 Mar;9(1):86-92. doi: 10.1111/ajco.12050. Epub 2012 Dec 27. Asia Pac J Clin Oncol. 2013. PMID: 23279888

10

Low expression of Beclin 1 and elevated expression of HIF-1α refine distant metastasis risk and predict poor prognosis of ER-positive, HER2-negative breast cancer.

Dong M, Wan XB, Yuan ZY, Wei L, Fan XJ, Wang TT, Lv YC, Li X, Chen ZH, Chen J, Lin Q, Wen JY, Ma XK, Liu Q, Wu XY. Dong M, et al. Med Oncol. 2013 Mar;30(1):355. doi: 10.1007/s12032-012-0355-0. Epub 2013 Feb 14. Med Oncol. 2013. PMID: 23408367

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,494 results

Search Page

Filters